5 Key Takeaways

• 1

  Researchers identified five plasma proteins that can predict metabolic dysfunction-associated steatotic liver disease up to 16 years before symptoms appear.

• 2

  The proteomic signature includes CDHR2, FUOM, KRT18, ACY1, and GGT1, showing 83.8% predictive accuracy five years prior to disease manifestation.

• 3

  Combining the protein markers with clinical parameters improved predictive accuracy to 90.4% at five years and 82.2% at 16 years.

• 4

  The study analyzed blood samples from over 50,000 participants in the UK Biobank, tracking health records for over 16 years.

• 5

  The predictive model was validated in a separate Chinese cohort, demonstrating its applicability across diverse populations.